Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 4 Apr 2024 Conference abstract · 30 Dec 2021 Role of Gene replacement therapy in children have infantile and later-onset spinal muscular atrophy (SMA): survival, motor function, motor milestone, clinical endpoints, and safety profile
prolong survival. This article aims to study the efficacy and safety of different gene replacement therapies in children with SMA. This systematic review and meta-analysis was conducted according ... asymptomatic drop…
Commentary · 26 Dec 2024 Gene Replacement Therapy in the Treatment of Severe Combined Immunodeficiency
Review article · 28 Dec 2020 Novel Approaches for Breast Cancer Screening and Treatment: A Review
treatments such as surgery, radiotherapy (non-drug therapy), chemotherapy, nanotechnology integration, or gene replacement therapy (drug-therapy
Research article · 30 Jul 2024 Gene Therapy for Parkinson’s Disease: Targeting Dopamine Replacement and Cell Function Modulation
have limitations and do not halt disease progression. Gene therapy presents a promising alternative by potentially modifying cellular behavior to replace lost dopamine or mitigate disease progression. This approach…
Short communication · 2011 Genetic therapy for primary immunodeficiency disease; SCID as an example
avoided, in the majority of patients, by early diagnosis and adequate treatment with immunoglobulin replacement therapy. Bone Marrow Transplantation (BMT) now offers the chance for curative treatment for some ... cells…
Conference abstract · 1 Mar 2020 Orphan Drugs 2020: Discovery of novel genes associated with mitochondrial diseases by NGS- Taosheng Huang- Cincinnati Children's Hospital Medical Center.
broad range of genetic disorders. Indeed, regulatory approval has recently been granted to gene replacement therapies for several disorders, including Leber congenital amaurosis type 2 (LCA2),1 spinal muscular atrophy…
Conference abstract · 6 Jun 2016 RPE65 deficiency: Natural history and insights from gene therapeutic trials
Leber Congenital Amaurosis LCA, early onset severe retinal dystrophy EOSRD and juvenile RP. Gene replacement therapy in dogs with naturally occurring mutations in RPE65 was very successful. To date
Other · 12 Jul 2016 Gene therapy in neurology: review of ongoing clinical trials
Gene therapy has entered into its third decade since the first human
Conference abstract · 11 Jun 2018 Synthetic messenger RNA-based therapeutic strategy for treatment of alpha-1- antitrypsin deficiency
Currently, AATD patients receive an AAT protein replacement therapy but it comes at undesirable side effects and high costs. In addition, gene therapy approaches are tested in clinical trials ... therapeutic strategy…
Conference abstract · 29 Feb 2016 Recent advances in stem cell biology and implications for tropical pathology practice
diseases ranging from leukemias, lymphomas and myelomas to sickle cell anemia and thalassemias. Replacement gene therapy is also becoming increasingly relevant, though ensuring efficient viral transduction of the…
Mini review · 29 Mar 2023 Gene Therapy for Mitochondrial Diseases: A Promising Approach to Restoring Mitochondrial Function
copies of genes into affected cells. The article discusses different gene therapy approaches, including viral vectors and mitochondrial replacement therapy, as well as the challenges that must be addressed ... ongoing…
Review article · 2017 Into the Eyes of Bone Marrow-Derived Mesenchymal Stem Cells Therapy for Myocardial Infarction and Other Diseases
MSCs have both important research significance and clinical application value in cell replacement therapy, gene therapy and reconstruction of tissues as well as organs especially for myocardial infarction. In this
Conference abstract · 19 Nov 2012 Nanoparticle-mediated ABCA4 delivery rescues the degenerative Stargardt�s phenotype
related macular degeneration, all diseases for which there are no curative therapies. Gene replacement is a logical strategy for ABCA4-associated disease, particularly given the current success of adeno-associated
Conference abstract · 5 Mar 2012 Subretinal Delivery of EIAV-based Lentiviral Vectors in the Shaker1 mouse model for Usher Syndrome Type 1B : Development of UshStat
high light intensity damage. These data support the development of an EIAV-based gene replacement therapy to treat Usher type 1B syndrome
Editorial · 2025 Gene Therapy: Advancements, Challenges, and Future Directions
Gene therapy represents a groundbreaking approach in modern medicine that aims to
Conference abstract · 3 Jul 2017 Human gene therapy - The road to today and beyond
approaches by gene replacement for loss-of-function genetic diseases, gene silencing for gain-of-function genetic disorders, gene editing for any genetic diseases and gene addition for treating acquired ... errors…
Perspective · 3 Jul 2023 Innovative Strategies for Liver Cancer: Ribozyme-Mediated RNA Replacement
Conference abstract Platelet-targeted gene therapy of hemophilia A and B
patients will develop inhibitory antibody after protein infusion, rendering the routine protein replacement therapy useless. Gene therapy is an attractive alternative for hemophilia treatment. It may provide sustained…
Research article · 13 May 2013 Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy
linked bleeding disorder. Current therapies include fixed-dose FVIII prophylaxis, factor replacement therapy, and most recently, gene therapy. Prophylaxis and FVIII replacement therapies are limited by incomplete…
Research article · 30 Apr 2014 Study on MSCs transplantation in respiratory diseases
number of diseases such as acute lung injury, pulmonary hypertension. Cell replacement and gene therapy is the development trend of the future. Bone marrow mesenchymal stem cells as a widely
Research article · 20 Mar 2013 How biotechnology will change healthcare?
human diseases involving defective genes, by replacing them with new, functional genes. Stem cell therapy aim is to replace the damaged cells with healthy, disease-free cells-hence the term
Conference abstract · 29 Nov 2011 Phenotypic correction of murine hemophilia a by bone marrow- derived liver cells
ineffi cient blood clotting.Current therapies include fi xed-dose FVIII prophylaxis, factor replacement therapies, and most recently, gene therapy. Liver is the primary site of FVIII synthesis; however, the specifi

